Mass spectrometry software BioPharma Compass®

for the pharmaceutical industryanalysisreporting

Comprehensive workflows for automated biopharmaceuticals characterization from acquisition to report generation in a single process. Simplicity Well documented and preinstalled workflow methods provide for a steep operator learning curve and fast return of investment. Automated result interpretation supports shortening analysis turn-around times. Versatility Adapts to user requirements and can be scaled from a single workstation to a client server network spanning a global biotech enterprise. Compliance The regulatory toolkit supports work under regulated conditions. The data mover enables data transfer to a protected server for utmost data security and access is limited through the database under audit trail. MAM analyses are enabled on the intact protein level as well as on the protein digest level Automation – entire workflows can be automatically performed, from acquiring LC-MS data to generating a report it’s a single process CFR 21 part 11 – compliance tools are on board, right after acquisition the data mover transfers data to a protected server Multi Attribute Methods (MAM) - allow to bring the focus of analysis where you need it. Fast and in-depth MAM assays are supported on the protein as well as the on the peptide level, respectively QC analysis - high throughput analyses by ESI and MALDI provide synthesis quality information, e.g., for peptides or oligonucleotides, and provide QC reports automatically based on intact mass measurements Ion mobility – using timsTOF instrument datasets, PASEF® data vastly increase the sequence coverage of biopharmaceuticals, the sensitivity in Host Cell Protein analysis (HCP)